However, IL-8 stimulates VEGF production in human bone marrow mesenchymal stem cells partially via the PI3K/Akt and MAPK/ERK signal transduction pathways and that administration of IL-8-treated human bone marrow mesenchymal stem cells increases angiogenesis after stroke (68). Here, CXCL8 is linked to stroke disorder.